Evidence map›Paper›PMID 42733538›Full record

ArticleBlood neoplasia2026

Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.

Isabelle Fleury, Brian T Hill, Toby A Eyre, Chaitra Ujjani, Beenish S Manzoor, Jennifer R Brown, Hande H Tuncer, Nicole Lamanna, Catherine C Coombs, Nilanjan Ghosh and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Isabelle FleuryCentre Hospitalier Universitaire de Québec, Université Laval, Quebec City, Canada.
Brian T HillCleveland Clinic, Cleveland, OH.
Toby A EyreChurchill Hospital, University of Oxford, Oxford, United Kingdom.
Chaitra UjjaniFred Hutchinson Cancer Research Center, Seattle, WA.
Beenish S ManzoorAbbVie, North Chicago, IL.
Jennifer R BrownDana-Farber Cancer Institute, Boston, MA.
Hande H TuncerDana-Farber Cancer Institute, Boston, MA.
Nicole LamannaColumbia University, New York, NY.
Catherine C CoombsUniversity of California Irvine, Irvine, CA.
Nilanjan GhoshLevine Cancer Institute/Atrium Health, Charlotte, NC.
Lori A LeslieJohn Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ.
Lindsey E RoekerMayo Clinic, Rochester, MN.
Nicolas Martinez-CalleNottingham University Hospitals, National Health Services Trust, Nottingham, United Kingdom.
Paul M BarrWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Matthew S DavidsDana-Farber Cancer Institute, Boston, MA.
Nnadozie EmechebeAbbVie, North Chicago, IL.
Joanna M RhodesRutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Alan P SkarbnikLymphoma and Chronic Lymphocytic Leukemia Program, Novant Health Cancer Institute, Charlotte, NC.
Wendy SinaiAbbVie, North Chicago, IL.
Laurie PearsonUniversity of Massachusetts, Worcester, MA.
Frederick LansiganDartmouth-Hitchcock Medical Center, Lebanon, NH.
Yun ChoiTufts Medical Center, Boston, MA.
Christopher E JensenLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Bita FakhriStanford Cancer Institute, Stanford University, Stanford, CA.
Meghan C ThompsonChronic Lymphocytic Leukemia Program, Leukemia Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.
Deborah M StephensLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Stephen J SchusterLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Michael CoyleLowell General Hospital, Lowell, MA.
Andres ChangWinship Cancer Institute of Emory University, Atlanta, GA.
Nancy KaddisDana-Farber Cancer Institute, Boston, MA.
Irina PivnevaAnalysis Group, Montreal, Canada.
Annie GuerinAnalysis Group, Montreal, Canada.
Mazyar ShadmanFred Hutchinson Cancer Research Center, Seattle, WA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42733538
PMCPMC13571241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.